It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication.
Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged.
It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School.
“There are so many other barriers to prescribing that we have to address,” said Chua.
The findings were published Wednesday in the New England Journal of Medicine.
Woman, 62, is left baffled as she turns up to a hospital scan only to be told she's already dead
China's gross marine product exceeds 9 trillion yuan in 2023
UNGA president advocates for sustainability in daily life
Rescue underway after earthquake hits Syria
These 15 AP photos capturing migrants' struggle were honored with a Pulitzer Prize
270 killed as deadly military conflict in Sudan rages into 4th day
G20 Summit to be held in Bali, Indonesia
American democracy in terminal decline
Quakes leave 1.5 mln people homeless in Türkiye: UN